← Eichor
Study identifier: NCT06989320 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease

Condition: Kidney Stones · Kidney Calculi · Urolithiasis  ·  Sponsor: University of Alabama at Birmingham

PhaseNA
Planned participants80
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersYes

About this study

The goal of this clinical trial study is to test if patients with idiopathic calcium oxalate kidney stones have an increased production of oxalate by the body, which would lead to increased urinary excretion of oxalate. The study will recruit adult patients with a history of calcium oxalate kidney stones and healthy volunteers without kidney stones. Participants will ingest fixed diets containing low amounts of oxalate for 5 days ingest a soluble form of glycolate and vitamin C collect urine, blood, stool during the dietary and oral dosing portions of the study and also collect breath sample during the oral glycolate test

This description comes directly from the study's public registry record.

Talk to the study team

Sonia Fargue, PhD  ·  205-975-6932  ·  sfargue@uabmc.edu

Always discuss trial participation with your own doctor first.

Locations (2)

United States, Alabama University of Alabama at BirminghamBirmingham, Alabama, United StatesRecruiting
University of Texas South Western Medical CenterDallas, Texas, United StatesNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06989320